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Abstract
Introduction: Escherichia coli infection is a major health concern 
for human immunodeficiency virus (HIV)/AIDS patients because it is 
a substantial cause of diarrhoea-associated morbidity and mortality.
Materials and Methods: Stool and blood samples were collected 
from 879 HIV/AIDS patients in a tertiary hospital in southwest Nige-
ria. The blood samples were screened for HIV IgM using competitive 
ELISA, and the concentration of the IgM was determined. The stool 
samples were cultured on eosin methylene blue agar. The isolates 
were characterised based on the production of green metallic sheen 
on EMB agar. DNA was extracted from all the isolates, and the extrac-
ted DNA was analysed by PCR with primers specifically targeting the 
virulence genes of enterohemorrhagic E. coli (EHEC), enteropathogenic 
E. coli (EPEC), enterotoxigenic E. coli (ETEC), and enteroinvasive E. coli 
(EIEC). Statistical analysis was conducted using the openepi online 
epidemiological package.
Results: All the blood samples tested positive for HIV IgM antibodies, 
and 80% had high concentration. All the stool samples were positive 
for E. coli, based on cell culture and DNA extraction. Of all the DNA 
tested by PCR using gene-specific primers targeting the 4 strains of 
E. coli, 222 samples were positive for EHEC shiga toxin 1 (stx1) gene, 
212 samples were positive for EPEC intimin (eaeA) gene, 289 were 
positive for EHEC serotype O157:H7 using the stx2a&b gene, 125 
were positive for EIEC haemolysin (hlyA) gene, and 31 were positive 
for ETEC uid gene.
Discussion: The high prevalence of E. coli O157:H7 is an indication 
that this strain, which has been previously linked with diarrhoea-re-
lated mortality in infants, may be responsible for most of the cases 
seen in HIV/AIDS patients. Though this strain is not common in adults, 
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Introduction
Chronic and persistent diarrhoea is a major cause of 
morbidity and mortality in people living with human 
immunodeficiency virus (HIV) and (AIDS). Diarrhoea 
occurs in almost 60-90% of people infected with 
HIV [1, 2]. Enteropathy is a common feature in HIV/
AIDS patients [3] which can alter the lamina propia 
pre-disposing these patients to enteric pathogens 
and infections even when the pathogens are at low 
concentration, in contrast low pathogen levels in 
immune competent individuals will produce mild or 
asymptomatic infection [2].
A wide range of enteric pathogens has been 
implicated in diarrhoea in HIV/AIDS patients. Of 
these pathogens E. coli is strongly associated with 
persistence diarrhoea with different virulent fac-
tors such as adhesion; invasion; with production 
of toxins such as shiga-toxin and vibrio like toxins 
which are responsible for different types of diarr-
hoea produced by E. coli [4,5]. Six strains of E. coli 
are known and each strain is associated with a 
different type of diarrhoea-associated virulent fac-
tor encoded by different genes. Enterotoxigenic E. 
coli (ETEC) encode genes for heat labile and heat 
stable enterotoxins while the bundle forming pillus 
and intimin (attachment and effacing; eaeA) genes 
are encoded by enteropathogenic E. coli (EPEC). 
The invasion plasmid antigen H (ipaH) and hae-
molysin (hlyA); vibrio-like toxin) genes are encoded 
by enteroinvasive E. coli EIEC). Enterohaemorrhagic 
E. coli (EHEC) encodes shiga-like toxin I (sltI) and 
shiga-like toxin II (sltII), Enteroaggregative E. coli 
(Eagg-EC), and diffusely adherent E. coli (DAEC) 
encodes the encodes the afimbrial adhesin gene 
[2]. The stx2A and stx2B genes are encoded by 
EHEC O157:H7 serotype (ECO157:H7) [6]. The uidA 
gene, which encodes the beta-glucuronidase can 
be used to identify EPEC.
In Nigeria, there have been a couple of studies 
on E. coli but none have characterised E. coli using 
molecular methods except a study by Okeke et al. 
[7] using hybridization technique and there study 
was from a different population. Though some 
studies have screened for some strains of E. coli, 
using the culture and serological methods and 
DNA hybridization, this will be the first molecular 
characterization (e.g. genotyping) of E. coli in HIV 
positive individuals. Vieira et al., [8] reported a high 




Blood (n=879) and stool (n=879) samples were co-
llected from individuals screened for HIV/AIDS at 
a tertiary health institution. All the subjects gave 
informed consent by filling out questionnaire. Sub-
jects were in four groups; HIV positive patients with 
diarrhoea (HIV+Dia+); HIV positive without diarrhoea 
(HIV+Dia-); HIV negative with diarrhoea (HIV-Dia+); 
HIV negative without diarrhoea (HIV-Dia-). Stool 
samples were collected from individuals positive 
and negative for HIV IgM antibodies, and negative 
samples acted as the control. The control subjects 
had no history of diarrhoea at least a month prior to 
its involvement in HIV/AIDS is indicative of suppressed immunity in 
this group of people. Other strains are also present in significant pro-
portions, indicating that these strains also constitute a public health 
concern, because they may be transmitted to infants or other immu-
nocompromised individuals. 
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clinical screen whether or not they were HIV+. Sub-
jects were defined as HIV positive with diarrhoea 
(Dia+HIV+; diarrhoea cases were defined as having 
frequent stooling more than 3 times a day), HIV 
positive and diarrhoea negative (Dia-HIV+), HIV ne-
gative and diarrhoea positive (Dia+HIV-), HIV nega-
tive and diarrhoea negative (Dia-HIV-). Though this 
study did not include a matched case control stu-
dy, questionnaire data collected from HIV+ subjects 
included age, sex, marital status, socio-economic 
status, medical history, access to portable water, 
and contact with animals. 
Blood processing
The blood samples were screened for HIV 1 
and 2 positivity using the ELISA kit as per the 
manufacturer’s instruction (WKEA Medical 
Supplies, China). The blood samples were collected 
into sterile vacutaners and immediately centrifu-
ged at 3000 rpm at room temperature (Beckman 
12), and sera were separated from all the samples 
and then stored at -4˚C. At the start of ELISA, the 
serum and the ELISA kits were allowed to come 
to room temperature. The IgM antibodies to both 
HIV 1 and 2 were detected by absorbance measu-
rement in a Thermomax Microplate Reader (Mole-
cular Devices, CA, USA); cut-offs were calculated 
as described by the manufacturer. 
Stool processing
The stool samples were collected into sterile con-
tainer; samples (1 g) were diluted in 9 mL of sterile 
water added to it to start a serial dilution process 
and 10-fold serial dilutions were carried out. From 
each of the dilutions, 0.1 mL was transferred onto 
eosin methylene blue agar using the pour-plate 
method and incubated at 37º C for 24 h. Those 
positive for E. coli were further confirmed by Gram 
staining, catalase, indole, coagulase, oxidase, urea-
se, gelatinase, niterate reduction, methyl red and 
Voges-Proskauer, citerate utilization, motility, and 
sugar fermentation (glucose, lactose, maltose, su-
crose, mannitol, fructose, and inositol). All confir-
med E. coli culture were sub-cultured into Luria 
broth for DNA extraction. 
DNA extraction and PCR
For DNA extraction, approximately 1000 µL of the 
broth was placed into Eppendoff microfuge tubes 
and centrifuged for 10 minutes at 10000 rpm for 
5 minutes, and then pellets were re-suspended in 
TE buffer. DNA was extracted was using a DNA 
extraction kit for bacteria (Norgen Biotek, Cana-
da) as directed by the manufacturer. Primers for 
PCR were custom designed using Biology Work 
bench with default parameters and all the gene 
sequences used for primer design were obtai-
ned from the Genbank. PCR was performed to 
amplify the following genes using the primers as 
follows:- for uidA (5’-GACGACTTGGTTGTGGA-
GGT-3’ and 5’-ATCCCCCTAAATCGATCACC-3’) en-
coded by ETEC generating a 921 bp product;, for 
stx2a&b (5’-TATATCAGTGCCCGGTGTGA-3’ and 
5’-TGTGACAGTGACAAACGCA-3’) encoded by E. 
coli O157:H7 strain and designed from gene se-
quence SM-25(1) stx-2 subunit A (stx2A) and stx2B 
complete CDS, generating a 1241 bp product,; 
for shiga toxin 1 gene (stx1) (5’-TGGTTGCGA-
AGGAATTTACC-3’and 5’-TGTGAAAAATCAGCA-
AAGCG-3’) encoded by the EHEC FE94195 strain 
and designed from partial stx1 gene for shiga toxin 
1 strain, generating 624 bp product;, for haemo-
lysin (hlyA) (5’-ATGCCTATTTCCGTGAGTGG-3’ and 
5’-CATTCTTCGCATTACGCTCA-3’) encoded by the 
Vibrio cholerae strain ATCC 14035 and designed 
from hlyA partial CDS, generating a 415 bp pro-
duct;, and for eaeA (5’-CAGCAAATCGAGCCA-
CAGTA-3’ and 5’-ACGATCCAGACCGTATTTGC-3’) 
encoded by EPEC strain E3-8- and designed for 
intimin gene partial CDS, generating a 918 bp pro-
duct. Primers for Eagg (5’CTGGCGAAAGACTGTAT-
CAT-3’ and 5’-CAATGTATAGAAATCCGCTGTT-3’) 
and ipaH (5’-GCTGGAAAAACTCAGTGCCT-3’ and 
5’-CCAGTCCGTAAATTCATTCT-3) were pre-desig-
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ned [2] for the virulent strains EaggEC and DAEC 
respectively and were obtained commercially (In-
qaba, South Africa). DNA was amplified using PCR 
2X Master Mix (Norgen Biotek, Canada) in a Hy-
baid Omnigene Thermocycler with the following 
condition: 1 cycle of denaturation at 95oC for 3 
mins and 40 cycles of annealing for 30 s at 55oC, 
and enlongation at 72oC for 5 mins. and 1 cycle 
of final enlongation for 1 min.
Results
Of the 879 stool samples screened for 5 different 
strains of E. coli based on virulence genes, 574 
(62.2%) were HIV+ of which 390 (67.7%) were 
from Dia+HIV+ patients and 186 (32.3%) were 
from Dia-HIV+ patients. Another 301 stool sam-
ples were from HIV- subjects, where 134 (63.8%) 
were Dia+HIV- and 76 (36.2%) were Dia-HIV-. The 
concentration of HIV IgM antibodies was higher 
in Dia+HIV+ samples than in Dia-HIV+ samples 
(Table 1), with the likelihood of having diarrhoea 
increasing as IgM concentration increase (Confi-
dence Interval (CI)=99%). All culture were positive 
for production of gas in glucose, galactose and 
lactose; they were positive for motility, indole, and 
methyl red. The finger print of all the PCR pro-
ducts was able to detect the genes targeted by 
each primer with varying prevalence (Fig. 1A-E). 
Age and sex were not associated with prevalen-
ce of diarrhoea in HIV- positive individuals as was 
the case without HIV (CI=99%), nor did increased 
IgM depend on age or sex (Table 2). The strain 
specific virulent genes detectable in HIV+ and in 
some controls samples and strain O157:H7 more 
frequently isolated in both cases and control com-
pared with other strains. EaggEC and DAEC were 
not detected while ETEC and EIEC were detected 
with low frequency. And ETEC was not extracted 
in Dia-HIV- individuals. Multiple genes were detec-
ted in Dia+HIV+ as against only 2 in Dia+HIV- (Table 
3). According to odds- based estimate, (Table 4) 
O157:H7 (Odd Ratio, OR=1.736), EPEC (OR=1.595) 
and EHEC (OR=1.338) were most frequently asso-
ciated with diarrhoea in the population .OR for all 
the multiple genes could not be determined be-
cause of too few or lack samples bearing multiple 
of E. coli genes. The etiological fraction (EF) of the 
general population (EFp/OR) was 27.54% (lower li-
mit= 6.605 and upper limit = 48.48) and the EF/OR 
in HIV+ patients was 36.91% (lower limit=3.291 
and upper limit= 58.84).
Table 1.  Concentration of HIV IgM in infected indi-












20 70 80 150 0.88 1
30 90 50 140 1.8 2.06
40 120 30 150 4 4.57
50 70 21 91 3.33 3.81
60 30 5 35 6 6.86
80 10 0 10 'undefined' 'undefined'
Total 390 186 576
Table 2.  Co-founding different HIV IgM concen-
trations using Mantel-Haenszel Summary 
Odds Ratios (OR) and Crude OR for con-






20 vs. 20: 1 1
30 vs. 20: 2.057 2.057
40 vs. 20: 4.571 4.571
50 vs. 20: 3.81 3.81
60 vs. 20: 6.857 6.857
80 vs. 20: 'undefined' 'undefined'
Extended Mantel-Haenzel Chi square for linear trend 
= 46.08 P-value for one degree of freedom = <0.0000001
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Table 3.  Distribution of E. coli strains identified by their virulence genes isolated from HIV-positive and 
HIV-negative individuals with or without diarrhoea.
Virus strains











1-tail 2-tail 1-tail 2-tail
Education
EPEC 98(75.4) 32(24.6) 48(65.8) 25(34.2) 0.09698 0.1940 0.07481 0.1496
EHEC 142(74.3) 49(25.9) 52(68.4) 24(31.6) 0.2030 0.4060 0.1661 0.3322
ETEC 16(94.1) 1(5.9) 9(100) 0(0) 0.6538(P) >0.9999999 0.3269(P) 0.6538
EIEC 30(85.7) 5(14.3) 9(90) 1(10) 0.5978(P) >0.9999999 0.3986(P) 0.7971
ECO157:H7 204(81.3) 47(18.7) 65(71.4) 26(28.6) 0.03676 0.07353 0.02785 0.05570
Multiple
EPEC and EHEC 11(91.7) 1(8.3) - -
EPEC and EIEC 1(100) - - - 0.8889(P) >0.9999999
EIEC and EHEC 1(100) - - -
EIEC and 
ECO157:H7
3(100) - - -
EPEC and 
ECO157:H7
31(88.6) 4(11.4) 1(100) -
EPEC, EHEC 
and ECO157:H7
7(77.8) 2(22.2) 1(100) - 0.8000(P) >0.9999999 0.4000(P) 0.8000
Crude 544(79.4) 141(20.6) 185(70.9) 76(29.1) 0.003827 0.007654 0.003060 0.006121
Adjusted 0.01353 0.02705 0.01108 0.02216
Table 4.  Odds-based estimates and confidence limits  of genes associated with different strains of diarr-
heagenic E. coli.
Virulence strains Odd Ratio
Confidence Limit (99%)
Fisher Exact Mid-Point Exact
Lower Upper Lower Upper
EPEC 1.595 0.6617 3.799 0.69 3.647
EHEC 1.338 0.5867 2.964 0.6095 2.863
ETEC 0.0 0.0 375.9 0.0 187
EIEC 0.6667 0.002508 12.48 0.005014 10.16
ECO157:H7 1.736 0.7938 3.696 0.8221 3.581
EPEC and EHEC undefined - - - -
EPEC and EIEC 0.0 0.0 1592 - -
EIEC and EHEC 'undefined - - - -
EIEC and ECO157:H7 undefined - - - -
EPEC and ECO157:H7 undefined - - - -
EPEC, EHEC and ECO157:H7 0.0 0.0 796 0.0 396
All Strains 1.585 1.016 2.453 1.029 2.423
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Virulence strains Odd Ratio
Confidence Limit (99%)
Fisher Exact Mid-Point Exact
Lower Upper Lower Upper
Crude CMLE Odds Ratio* 1.584 1.029, 2.423¹ Mid-P Exact  
1.016, 2.453¹ Fisher Exact
Odds Ratio 1.585 1.034, 2.429¹ Taylor series
Etiologic fraction in pop.(EFp|OR) 27.54% 6.605, 48.48
Etiologic fraction in exposed(EFe|OR) 36.91% 3.291, 58.84
Adjusted CMLE Odds Ratio* 1.476 0.9515, 2.276¹ Mid-P Exact
0.9391, 2.304¹ Fisher Exact
Directly Adjusted OR '?' '?', '?'¹ Taylor series




Breslow-Day test for interaction of 
Odds Ratio over strata:
2.964 0.6095 
chi square= '?' p =  NaN
p greater than 0.05 does not 
suggest interaction. Adjusted OR 
can be used.
0.002508 12.48 0.005014
Figure 1:  a: PCR amplification pattern of shiga toxin 2 (stx2A and stx2B) subunit genes encoded by E. coli 
O157:H7
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Figure 1:  d: PCR amplification pattern of intimin gene (eaeA) encoded by EPEC.
Figure 1:  e: PCR amplification pattern of uid encoded by EIEC.
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Discussion
In sub-saharan Africa and most developing and 
underdeveloped world, diarrhoea- causing- E. coli 
are a significant cause of morbidity and mortali-
ty in young infants. In contrast, adults are usually 
asymptomatic visible infection in adults is usually 
self-limiting. However, in the HIV/AIDS patients dia-
rrhoea due to E. coli has become a leading cause 
of morbidity and mortality in adults as well, which 
is well documented [9]. High levels of HIV IgM in 
patients with diarrhoea confirm that these patients 
are in the acute or early stage of HIV infection prior 
to seroconversion [10]. In this study, these patients 
were also among those with multiple genes (strains) 
of E. coli. The aetiological fraction of those positive 
for HIV was more than that of the general popula-
tion, hence serostatus of the HIV+ individuals is likely 
responsible for diarrhoea in this group of people, 
and the different E. coli virulence genes accounts 
for this diarrhoea. This result supports the idea that 
proper management of diarrhoea in the acute pha-
se of HIV infection is necessary, as diarrhoea itself 
is a serious source of morbidity in those living with 
HIV/AIDS especially presenting in the early phase of 
the infection of which this study further confirms 
an earlier study by Gassama-Sow et al., [2].
There was no significant association between pa-
tients’ age or sex and E. coli strain-specific virulence 
genes which correlates earlier reports on infants [11]. 
However, results of a study in Lima, Peru surprisingly 
deviated from these earlier reports. Medina et al., 
[12] reported a significant association in both age 
and sex in E coli carriage when they studied diarr-
hoea-causing E. coli strains in infants. Reports indi-
cate that diarrhoeagenic E. coli are moslyt isolated 
from immunocompromised patients with diarrhoea 
[13] but strains could vary from regionally; conse-
quently, regional interpretation of results must be 
taken into account, especially in clinical settings, to 
enhance proper management of diarrhoea in HIV+ 
patients. Of patients in Nigeria, this is the first study 
to genotypically characterize E. coli in HIV patients 
by E. coli strain-specific virulent genes. Earlier studies 
characterized diarhoeagenic E. coli serotypically, and 
though Nweze [14] identified some of these strains 
using PCR, the strains were not characterized using 
the method described here. Okeke et al., [7] used 
a DNA hybridization technique characterized E. coli 
strains but this does not underscore PCR relative to 
sensitivity and specificity.
 EHEC serotype ECO157:H7 has been detected 
from various parts of the world from specific out-
breaks in the normal population of which infants 
have been worst hit, including outbreaks reported 
by Riley et al,. [15] in the United States, by Morgan 
et al., [16] in Britain, by Effler et al., [17] Swatziland, 
by Koyange et al., [18] in Democratic Republic of 
Congo. In Nigeria, a prevalence study of ECO157H7 
included report from southwest Nigeria by Ogun-
sanya et al., [19]; Okeke et al., [7] and; Olorunshola 
et al., [20].Esumeh et al., [21] also reported a si-
milar high prevalence of ECO157:H7 in Benin City, 
Nigeria. In this study high prevalence of ECO157:H7 
serotype was associated with a high risk population. 
Although other studies also showed a high preva-
lence of ECO157:H7, these studies were mainly on 
infants and not on immunocompromised individuals. 
We confirm that ECO157:H7 accounted for 81.3% 
of diarrhoea cases among HIV+ patients even when 
ECO157:H7 is an emerging EHEC serotype that is 
not well documented in Nigeria or in other parts of 
developing world. According to odd- based analy-
sis, ECO157:H7 has the highest ability to diarrhoea 
among HIV+ patients which correspond to a similar 
result from an earlier report [21]. Hence, isolation 
of ECO157:H7 depended on the HIV status of the 
subjects in this study.
EPEC is an important diarrhoeagenic pathogen, 
which has been recognized as a highly prevalent 
cause of diarrhoea in Nigeria [7,14]. This study also 
confirmed that EPEC is a major cause diarrhoea sin-
ce it was detected in 75% of all the cases. EPEC 
is an important strain because it is linked to acute 
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watery diarrhoea and persistent diarrhoea in in-
fants and in immuno compromised patients, and it 
leads to high morbidity and mortality rates greater 
than 50% in HIV+ patients, especially in developing 
countries [2]. Medina et al., [12] reported that EPEC 
strains could be a concern for HIV+ patients but the 
study examined only children. Gassama-Sow et al., 
[2] also showed a high prevalence of EPEC in HIV+ 
individuals in Senegal which is in agreement with 
our study and another study in the Netherlands [22].
EHEC which was isolated with high frequency in 
the HIV cases and in some of the controls was also 
incriminated in this study as a cause of diarrhoea 
in HIV+ individuals, the odds of causing diarrhoea 
in the HIV cases was 1.338 (CI=99%) though data 
are scarce with regards of EHEC causing diarrhoea 
in Nigeria in both adults and infants. Okeke et al., 
[7] used DNA hybridization and detected EHEC in 
infants for only a small proportion (0.5%) of total 
positive individuals. The high prevalence in this stu-
dy may be connected with the fact that the popu-
lation in this study was immunocompromised and 
that the PCR method used in this study is more 
sensitive than the hybridization techniques used by 
Okeke et al., [7]. The virulence pattern of EHEC has 
changed with the advent of HIV/AIDS. However, 
earlier studies by Okeke et al., [7] and Nweze [14] 
did not distinguish the serotype ECO157:H7 from 
the EHEC strain. 
ETEC, which causes dehydrating diarrhoea becau-
se of heat-stable and heat-labile enterotoxins was 
isolated with low frequency in Nigeria and in HIV+ 
individuals and was less likely to cause diarrhoea in 
HIV+ individuals (CI=99%). ETEC has also been isola-
ted with low frequency in infants with diarrhoea in 
several studies from several geographical locations 
[2, 7, 12,23]. 
Results from this study also incriminated EIEC as 
a causal strain for diarrhoea in those infected with 
HIV. Although not much is known about EIEC in 
Nigeria, deteriorating immune statuses in HIV/AIDS 
patients have made EIEC an emerging strain, though 
a study by Gassama-Sow et al., [2] observed that 
EIEC infection was not dependent on HIV infection 
according to serostatus, because no asymptomatic 
carriage was found in their study. They reported 
that 95 screened HIV+ individuals did not present 
EIEC of the total 182 stool samples. In this study, 
30 of the total 833 stool samples yielded EIEC from 
Dia+HIV+ individuals as compared to 5 from Dia-
HIV+ individuals. Coupled with the fact that EIEC 
is scarcely reported in Nigeria, it is then reasonable 
to assume that EIEC was a causative agent of dia-
rrhoea in HIV+ individuals. Vieira et al., [8] also re-
ported a high prevalence of EIEC in costal Ecuador, 
though they did not stratify the population. Further, 
Okeke et al., [7] reported the possibility of EIEC in 
childhood diarrhoea in Nigeria but very little has 
been reported about EIEC in Nigeria after 2000. 
EaggEC and DAEC was not implicated as a probable 
cause of diarrhoea in this study. Although this strain 
is also said to be emerging and is not common to 
Nigeria, more researches should be conducted in 
the general population.
Multiple infections by different strains did not 
prove to be a cause of diarrhoea in HIV+ indivi-
duals or in the general population, as there were 
too few samples in which multiple strains were de-
tected to determine their collective role in diarrhoea 
causation. This result supports an earlier report by 
Gassama-Sow et al., [2] regarding, subjects from 
Senegal which is also a West African country where 
geographical data may be similar.
High resistance to tetracycline, cotrimoxazole and 
ampicillin was observed for EIEC, ECO157:H7, and 
ETEC strains. This resistance may be due to exposu-
re of the strains to selective pressure since most of 
these antibiotics are used heavily in the treatment 
of diarrhoea and are heavily abused. 
In conclusion, strains of E. coli possess great con-
cern in HIV+ especially at the acute phase of HIV 
infection even before seroconversion and probably 
through the course of infection. Proper manage-
ment is highly required in HIV+ individuals to redu-
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ce morbidity and mortality. And such management 
should be geographically considered as different 
strains may dominate different geographical loca-
tions. This will reduce multiple drug resistance cu-
rrently seen in most strains. 
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